Recent Finacing
Recent Raise
Eleva uses a moss-based bioproduction platform to manufacture biologics — antibodies, replacement enzymes, and fusion toxins — and advances drug candidates such as CPV-101 into clinical stages.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Eleva.
